Credit Agricole S A Immuno Gen, Inc. Transaction History

Credit Agricole S A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $182,225 - $239,217	-36,300 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $117,000 - $189,540	18,000 Added 98.36%	36,300 $294,000
Q4 2020 Feb 12, 2021	BUY	$3.7 - $7.66 $17,760 - $36,768	4,800 Added 35.56%	18,300 $118,000
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $7,420 - $23,800	3,500 Added 35.0%	13,500 $46,000
Q1 2019 May 14, 2019	BUY	$2.41 - $5.91 $24,100 - $59,100	10,000 New	10,000 $27,000
Q3 2017 Nov 14, 2017	SELL	$5.4 - $8.47 $140,400 - $220,220	-26,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	26,000	26,000 $185,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.